BridgeBio Pharma (BBIO)
(Delayed Data from NSDQ)
$24.88 USD
+0.55 (2.26%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $24.91 +0.03 (0.12%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Earnings News For BBIO
-
Will BridgeBio Pharma (BBIO) Report Negative Q1 Earnings? What You Should Know
-
BridgeBio Pharma: Q4 Earnings Snapshot
-
BridgeBio Pharma: Q4 Earnings Snapshot
-
BridgeBio Pharma (BBIO) Reports Q4 Loss, Lags Revenue Estimates
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
-
Analysts Estimate BridgeBio Pharma (BBIO) to Report a Decline in Earnings: What to Look Out for
-
BridgeBio Pharma: Q3 Earnings Snapshot
-
BridgeBio Pharma Reports Third Quarter 2023 Financial Results and Business Update
-
BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
BridgeBio Pharma (BBIO) Reports Q2 Loss, Misses Revenue Estimates
-
BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
-
BridgeBio Pharma (BBIO) Reports Q1 Loss, Lags Revenue Estimates
-
BridgeBio Pharma: Q1 Earnings Snapshot
-
BridgeBio Pharma Reports First Quarter 2023 Financial Results and Business Update
-
BridgeBio Pharma (BBIO) Reports Q4 Loss, Lags Revenue Estimates
-
BridgeBio Pharma: Q4 Earnings Snapshot
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2022 Financial Results and Business Update
-
Will BridgeBio Pharma (BBIO) Report Negative Q4 Earnings? What You Should Know
-
BridgeBio Pharma (BBIO) Reports Q3 Loss, Misses Revenue Estimates
-
BridgeBio Pharma: Q3 Earnings Snapshot
-
BridgeBio Pharma, Inc. Reports Third Quarter 2022 Financial Results and Business Update
-
Will BridgeBio Pharma (BBIO) Report Negative Q3 Earnings? What You Should Know
-
BridgeBio Pharma (BBIO) Reports Q2 Loss, Tops Revenue Estimates
-
BridgeBio Pharma: Q2 Earnings Snapshot
-
BridgeBio Pharma, Inc. Reports Second Quarter 2022 Financial Results and Business Update